A Boston woman's call to a popular finance show reveals a marriage buckling under the weight of multi-million dollar real estate debt and conflicting risk appetites, highlighting how financial discord can threaten relationships.
A 24-year-old's father asked her to pay the premiums on his life insurance policy, framing it as an investment for her future. Personal finance expert Dave Ramsey and his co-host Ken Coleman weighed in on the emotional and financial pitfalls of such an arrangement.
New clinical imaging data for Molecular Partners' experimental radiotherapeutic MP0712, targeting the DLL3 protein in cancers like small cell lung cancer, show favorable tumor targeting and healthy organ clearance. The company confirms its U.S. Phase I/II trial is now open for patient screening.
In a stark episode of his show, personal finance expert Dave Ramsey labeled a husband's control over family finances as '100% abusive.' The case highlights how economic manipulation traps victims, a pattern experts say underpins nearly all domestic violence.
Oppenheimer upgrades Relay Therapeutics (RLAY) to Outperform, citing the strength of its mutant-selective inhibitor pipeline and upcoming catalysts in the breast cancer treatment arena.
New long-term results from the pivotal EMBARK trial indicate ELEVIDYS, Sarepta's gene therapy, continues to alter the disease trajectory for boys with Duchenne muscular dystrophy, with no new safety concerns emerging over three years.
This week's Big Tech earnings revealed a stark divide: companies using existing cash cows to fund AI ambitions versus those betting the farm on a future payoff. The market's patience for visionary spending is wearing thin, demanding concrete timelines and a path to profit.
A Utah couple with a $180,000 income sought advice on using a $7,300 bonus. Dave Ramsey's firm counsel: shore up emergency savings, attack their HELOC debt, and postpone both a long-awaited honeymoon and speculative IPO investing until their financial foundation is secure.
LVMH's recent 0.8% single-day gain to €546.9 offers a glimmer of hope after a period of weaker performance, sparking debate among analysts over whether the market is underestimating the luxury conglomerate's long-term resilience and global footprint.
A mixed third-quarter earnings season for therapeutics stocks reveals divergent paths, with United Therapeutics missing estimates while peers like Halozyme and Biogen post strong beats. Sector-wide revenue growth and positive stock reactions suggest underlying investor confidence despite regulatory and pricing headwinds.
Financial planners are urging a shift in mindset: the date on your retirement party invitation matters less than the balance in your investment portfolio. We break down the calculations that show whether you're truly ready to leave the workforce.
In a volatile market, certain low-priced Asian stocks are drawing attention not just for their valuation, but for underlying financial strength. We examine three such companies—from healthcare in New Zealand to property services in Greater China—that defy the typical 'penny stock' stereotype with solid fundamentals.
New data reveals U.S. homeowners are holding onto their properties longer than at any point in the last quarter-century, with coastal markets showing the most pronounced stagnation. High mortgage rates, soaring prices, and a severe inventory crunch have created a powerful 'lock-in' effect, reshaping the dynamics of the housing market.
Authorities in Arizona are conducting an urgent search for Nancy Guthrie, 84, the mother of 'Today' show co-anchor Savannah Guthrie, who vanished from her home near Tucson. The family and sheriff's office emphasize her need for daily medication and say her disappearance is out of character.
While broader UK indices face headwinds, a closer look reveals potential in smaller-cap companies. We examine three penny stocks—Alumasc Group, Mercia Asset Management, and Roebuck Food Group—that are navigating economic challenges with distinct strategies and financial profiles.
Northwest Bancshares' Q4 results showcased the initial impact of its Penns Woods acquisition, boosting revenue and margins. While management struck a confident tone on integration, analyst questions during the earnings call revealed a sharper focus on the sustainability of growth, cost savings, and competitive pressures in a shifting rate environment.
Despite a strong 33% gain over the past year, Lear Corporation's recent stock performance shows signs of cooling. A deep dive into its discounted cash flow and earnings multiples suggests the market may still be undervaluing this automotive seating and electronics supplier.
Amid broader market uncertainty, companies with high insider ownership and robust earnings forecasts can signal aligned interests and resilience. We examine three such UK-listed firms, from a gold miner to a convenience food giant, where those running the show have significant personal stakes.
Columbia Financial (CLBK) announces a major executive reshuffle, promoting its long-time CFO to Chief Banking Officer and appointing a new finance chief. The move comes as the stock shows recent gains but longer-term weakness, raising questions about its current valuation and future trajectory.
AerCap Holdings' stock has soared over 50% in the past year, but recent trading shows momentum stalling. With shares trading below a key fair value estimate, investors are weighing whether the market has already priced in the recovery or if there's still room to climb.
